The decline in stroke hospitalization due to COVID-19 is unrelated to COVID-19 intensity
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
36511840
PubMed Central
PMC9877601
DOI
10.1111/ene.15664
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, Czech Republic, intravenous thrombolysis, mechanical thrombectomy, stroke,
- MeSH
- cévní mozková příhoda * terapie MeSH
- COVID-19 * MeSH
- hospitalizace MeSH
- ischemická cévní mozková příhoda * MeSH
- ischemie mozku * terapie MeSH
- lidé MeSH
- pandemie MeSH
- trombektomie metody MeSH
- trombolytická terapie metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND AND PURPOSE: During the coronavirus disease 2019 (COVID-19) pandemic many countries reported a decline in stroke volumes. The aim of this study was to analyze if the decline was related to the intensity of the COVID-19 pandemic. METHODS: The first pandemic year (1 March 2020 to 28 February 2021) overall and during the three COVID-19 waves were compared with the preceding year. Volumes of acute ischaemic stroke (AIS), subarachnoid hemorrhage, intracerebral hemorrhage and recanalization treatments (intravenous thrombolysis [IVT] and mechanical thrombectomy [MT]) were obtained from the National Register of Reimbursed Health Services. Door-to-needle time, onset-to-door time and National Institutes of Health Stroke Scale at admission were obtained from the Registry of Stroke Care Quality. RESULTS: During the pandemic year compared to the preceding year there were 26,453 versus 28,771 stroke admissions, representing an 8.8% decline (p < 0.001). The declines (-10%, -11%, -19%) appeared in COVID-19 waves (spring 2020, autumn 2020, winter 2021) except for an increase (2%) during summer 2020. Admissions for AIS declined by 10.2% (p < 0.001), whilst hemorrhagic stroke volumes were minimally decreased. The absolute volumes of IVT and MT decreased by 9.4% (p < 0.001) and 5.7% (p = 0.16), respectively. However, the proportions of ischaemic stroke patients receiving IVT (18% vs. 18%; p = 0.72) and MT (6% vs. 6%; p = 0.28) remained unchanged. CONCLUSIONS: There was a decline in stroke admissions, but such decline was not related to COVID-19 incidence. The frequency of use of recanalization procedures (IVT, MT) and times (onset-to-door time, door-to-needle time) in AIS were preserved in the Czech Republic during the first year of the pandemic.
Department of Neurology Mayo Clinic Rochester Minnesota USA
Faculty of Medicine Institute of Biostatistics and Analyses Masaryk University Brno Czech Republic
Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Neurological Department and Stroke Unit Jihlava Hospital Jihlava Czech Republic
Zobrazit více v PubMed
Esenwa C, Parides MK, Labovitz DL. The effect of COVID‐19 on stroke hospitalizations in New York City. J Stroke Cerebrovasc Dis. 2020;29(10):105114. PubMed PMC
Romoli M, Eusebi P, Forlivesi S, et al. Stroke network performance during the first COVID‐19 pandemic stage: a meta‐analysis based on stroke network models. Int J Stroke. 2021;16(7):771‐783. PubMed PMC
Richter D, Eyding J, Weber R, et al. Analysis of nationwide stroke patient care in times of COVID‐19 pandemic in Germany. Stroke. 2021;52(2):716‐721. PubMed PMC
de Havenon A, Yaghi S, Majersik JJ, et al. Acute coronary syndrome and ischemic stroke discharges in the United States during the COVID‐19 pandemic. Stroke. 2021;52(6):e239‐e241. PubMed PMC
Kristoffersen ES, Jahr SH, Thommessen B, Rønning OM. Effect of COVID‐19 pandemic on stroke admission rates in a Norwegian population. Acta Neurol Scand. 2020;142(6):632‐636. PubMed PMC
Katsanos AH, Palaiodimou L, Zand R, et al. Changes in stroke hospital care during the COVID‐19 pandemic: a systematic review and meta‐analysis. Stroke. 2021;52(11):3651‐3660. PubMed PMC
Bres Bullrich M, Fridman S, Mandzia JL, et al. COVID‐19: stroke admissions, emergency department visits, and prevention clinic referrals. Can J Neurol Sci. 2020;47(5):693‐696. PubMed PMC
Bersano A, Kraemer M, Touzé E, et al. Stroke care during the COVID‐19 pandemic: experience from three large European countries. Eur J Neurol. 2020;27(9):1794‐1800. PubMed PMC
Douiri A, Muruet W, Bhalla A, et al. Stroke care in the United Kingdom during the COVID‐19 pandemic. Stroke. 2021;52(6):2125‐2133. PubMed PMC
Uchino K, Kolikonda MK, Brown D, et al. Decline in stroke presentations during COVID‐19 surge. Stroke. 2020;51(8):2544‐2547. PubMed PMC
Altersberger VL, Stolze LJ, Heldner MR, et al. Maintenance of acute stroke care service during the COVID‐19 pandemic lockdown. Stroke. 2021;52(5):1693‐1701. PubMed PMC
Diegoli H, Magalhães PSC, Martins SCO, et al. Decrease in hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID‐19 era. Stroke. 2020;51(8):2315‐2321. PubMed PMC
Gdovinová Z, Vitková M, Baráková A, Cvopová A. The impact of the COVID‐19 outbreak on acute stroke care in Slovakia: data from across the country. Eur J Neurol. 2021;28(10):3263‐3266. PubMed
Nogueira RG, Qureshi MM, Abdalkader M, et al. Global impact of COVID‐19 on stroke care and IV thrombolysis. Neurology. 2021;96(23):e2824‐e2838. PubMed PMC
Rudilosso S, Laredo C, Vera V, et al. Acute stroke care is at risk in the era of COVID‐19: experience at a Comprehensive Stroke Center in Barcelona. Stroke. 2020;51(7):1991‐1995. PubMed PMC
Sacco S, Ricci S, Ornello R, Eusebi P, Petraglia L, Toni D. Reduced admissions for cerebrovascular events during COVID‐19 outbreak in Italy. Stroke. 2020;51(12):3746‐3750. PubMed PMC
Siegler JE, Heslin ME, Thau L, Smith A, Jovin TG. Falling stroke rates during COVID‐19 pandemic at a comprehensive stroke center. J Stroke Cerebrovasc Dis. 2020;29(8):104953. PubMed PMC
Zhao J, Li H, Kung D, Fisher M, Shen Y, Liu R. Impact of the COVID‐19 epidemic on stroke care and potential solutions. Stroke. 2020;51(7):1996‐2001. PubMed PMC
Kerleroux B, Fabacher T, Bricout N, et al. Mechanical thrombectomy for acute ischemic stroke amid the COVID‐19 outbreak: decreased activity, and increased care delays. Stroke. 2020;51(7):2012‐2017. PubMed
Sedova P, Brown RD Jr, Bryndziar T, et al. Treat COVID‐19, but not only COVID‐19: stroke matters as well. Cerebrovasc Dis. 2022;51(1):52‐59. PubMed PMC
Rinkel LA, Prick JCM, Slot RER, et al. Impact of the COVID‐19 outbreak on acute stroke care. J Neurol. 2021;268(2):403‐408. PubMed PMC
Drenck N, Grundtvig J, Christensen T, et al. Stroke admissions and revascularization treatments in Denmark during COVID‐19. Acta Neurol Scand. 2022;145(2):160‐170. PubMed PMC
Ghoreishi A, Arsang‐Jang S, Sabaa‐Ayoun Z, et al. Stroke care trends during COVID‐19 pandemic in Zanjan Province, Iran. From the CASCADE initiative: statistical analysis plan and preliminary results. J Stroke Cerebrovasc Dis. 2020;29(12):105321. PubMed PMC
De Marchis GM, Wright PR, Michel P, et al. Association of the COVID‐19 outbreak with acute stroke care in Switzerland. Eur J Neurol. 2022;29(3):724‐731. PubMed PMC
Yu AYX, Lee DS, Vyas MV, et al. Emergency department visits, care, and outcome after stroke and myocardial infarction during the COVID‐19 pandemic phases. CJC Open. 2021;3(10):1230‐1237. PubMed PMC
Raymaekers V, Demeestere J, Bellante F, et al. The impact of COVID‐19 on acute stroke care in Belgium. Acta Neurol Belg. 2021;121(5):1251‐1258. PubMed PMC
Ortega‐Gutierrez S, Farooqui M, Zha A, et al. Decline in mild stroke presentations and intravenous thrombolysis during the COVID‐19 pandemic: the Society of Vascular and Interventional Neurology Multicenter Collaboration. Clin Neurol Neurosurg. 2021;201:106436. PubMed PMC
Tanisaka LS, Paiva LDS, Werneck de Carvalho LE, et al. Stroke hospital admissions during the COVID‐19 outbreak in São Paulo, Brazil. Cerebrovasc Dis. 2022;51(5):686‐689. PubMed PMC
Markus HS, Martins S. COVID‐19 and stroke—understanding the relationship and adapting services. A global world stroke organisation perspective. Int J Stroke. 2021;16(3):241‐247. PubMed PMC
Benali F, Stolze LJ, Rozeman AD, et al. Impact of the lockdown on acute stroke treatments during the first surge of the COVID‐19 outbreak in the Netherlands. BMC Neurol. 2022;22(1):22. PubMed PMC
Ritchie H ME, Rodés‐Guirao L, Appel C, Giattino C, Ortiz‐Ospina E, Hasell J, Macdonald B, Beltekian D, Roser M. Czechia: coronavirus pandemic country profile. https://ourworldindata.org/coronavirus/country/czech‐republic. Published 2020. Accessed September 19, 2022.
Demaerschalk BM. Where in the world have all the strokes gone? Neurology. 2021;96(23):1069‐1070. PubMed
Richter D, Eyding J, Weber R, et al. A full year of the COVID‐19 pandemic with two infection waves and its impact on ischemic stroke patient care in Germany. Eur J Neurol. 2022;29(1):105‐113. PubMed PMC
Fuentes B, Alonso de Leciñana M, Rigual R, et al. Fewer COVID‐19‐associated strokes and reduced severity during the second COVID‐19 wave: the Madrid stroke network. Eur J Neurol. 2021;28(12):4078‐4089. PubMed PMC
Katsouras C, Tsivgoulis G, Papafaklis M, et al. Persistent decline of hospitalizations for acute stroke and acute coronary syndrome during the second wave of the COVID‐19 pandemic in Greece: collateral damage unaffected. Ther Adv Neurol Disord. 2021;14:17562864211029540. PubMed PMC